RC48-ADC Combined With S-1 for First-line Treatment of Advanced Gastroesophageal Adenocarcinoma With Moderate Expression of HER2

NCT05403242 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Advanced Gastroesophageal Adenocarcinoma

Interventions

DRUG: RC48-ADC
DRUG: S-1

Sponsor

Chinese PLA General Hospital